Intermittent Positive-Pressure Breathing

Subscribe to Selected New Research on Intermittent Positive-Pressure Breathing

175 relevant articles (15 outcomes, 22 trials/studies) found for this Therapy

Description: Application of positive pressure to the inspiratory phase of spontaneous respiration.

Also Known As:

Intermittent Positive Pressure Breathing (IPPB); Breathing, Inspiratory Positive-Pressure; Breathing, Intermittent Positive-Pressure; Inspiratory Positive Pressure Breathing; Intermittent Positive Pressure Breathing; Positive-Pressure Breathing, Inspiratory; Positive-Pressure Breathing, Intermittent; IPPB; Inspiratory Positive-Pressure Breathing

Relationship Network

Therapy Context: Research Results

Therapeutics: 5229

Respiratory Therapy: 481

Artificial Respiration: 7808

Positive-Pressure Respiration: 2527

Intermittent Positive-Pressure Breathing: 175

Experts

1.	Le Bomin, Elisabeth: 1 article (08/2008)
2.	Ruquet, Maria: 1 article (08/2008)
3.	Falaize, Line: 1 article (08/2008)
4.	Laffont, Isabelle: 1 article (08/2008)
5.	Denys, Pierre: 1 article (08/2008)
6.	Hutin, Claudette: 1 article (08/2008)
7.	Bensmail, Djamel: 1 article (08/2008)
8.	Lortat-Jacob, Sylvie: 1 article (08/2008)
9.	Lofaso, Frédéric: 1 article (08/2008)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 07/01/1979 - "Because a previous retrospective study did not allow any conclusion as to the efficacy of home IPPB therapy in patients with chronic airflow obstruction, a control trial has been started" 08/01/1995 - "PARTICIPANTS: Nine hundred eighty-five patients with moderate to severe COPD enrolled in the Intermittent Positive Pressure Breathing (IPPB) Trial" 08/01/1992 - "The study focuses specifically on the use of IPPB to treat inpatients with chronic obstructive pulmonary disease in a national sample of more than 500 community hospitals from 1980 to 1987" 03/01/1986 - "To evaluate the role of ventilatory muscle endurance training (VMET) in the rehabilitation of outpatients with chronic obstructive pulmonary disease, we carried out a prospective random allocation trial of VMET versus IPPB" 11/01/1985 - "We examined the lungs from 48 autopsied patients in the National Institutes of Health Intermittent Positive-Pressure Breathing trial who had moderately severe and severe chronic airflow obstruction" Order ALL the reference details at left...
2.	Asthma (Bronchial Asthma) 05/01/1983 - "Whether or not intermittent positive pressure breathing (IPPB) is beneficial in the treatment of asthma has been controversial for 30 years" 05/01/1983 - "With evidence from a literature review, it is concluded that in cases of severe asthma failing to respond to other methods of beta-agonist inhalation, there is sufficient evidence for the use of IPPB." 05/01/1983 - "Intermittent positive pressure breathing and the treatment of acute asthma." 07/01/1978 - "The results show that both methods produce significant bronchodilatation even in patients admitted with moderately severe asthma (FEV1 about 38% predicted) but a slightly greater improvement may be achieved by IPPB nebulization" 03/01/1978 - "Intermittent positive-pressure breathing in asthma." Order ALL the reference details at left...
3.	Pneumonia (Pneumonitis) 02/01/1979 - "Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia." 09/21/1978 - "We undertook a randomized clinical trial to evaluate the efficacy of chest physiotherapy and intermittent positive-pressure breathing in the treatment of pneumonia" 09/21/1978 - "Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia." 09/21/1978 - "Chest physiotherapy and intermittent positive-pressure breathing do not hasten the resolution of pneumonia." 01/01/2007 - "There was no significant difference in pulmonary complications (atelectasis and pneumonia) between treatment with incentive spirometry and treatment with positive pressure breathing techniques (continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP) and intermittent positive pressure breathing (IPPB)) or preoperative patient education" Order ALL the reference details at left...
4.	Cough 06/01/2006 - "The aim of this study was to investigate whether hyperinsufflation with an intermittent positive-pressure breathing (IPPB) device is effective in cough augmentation in pediatric patients" 03/01/1968 - "Effect of intermittent positive pressure breathing and use of rebreathing tube upon tidal volume and cough." 12/01/2006 - "Of 13 trials with a "no intervention" control group, 9 studies (n = 883) did not report on significant differences, and 4 studies (n = 528) did: in 1 study, the incidence of pneumonia was decreased from 37.3 to 13.7% with deep breathing, directed cough, and postural drainage (RD, 23.6%; 95% CI, 7 to 40%; NNT, 4.3; 95% CI, 2.5 to 14); in 1 study, the incidence of atelectasis was decreased from 39 to 15% with deep breathing and directed cough (RD, 24%; 95% CI, 5 to 43%; NNT, 4.2; 95% CI, 2.4 to 18); in 1 study, the incidence of atelectasis was decreased from 77 to 59% with deep breathing, directed cough, and postural drainage (RD, 18%; 95% CI, 5 to 31%; NNT, 5.6; 95% CI, 3.3 to 19); in 1 study, the incidence of unspecified pulmonary complications was decreased from 47.7% to 21.4 to 22.2% with intermittent positive pressure breathing, or incentive spirometry, or deep breathing with directed cough (RD, 25.5 to 26.3%; NNT, 3.8 to 3.9)" 04/01/2001 - "In patients with low lung volumes resulting from neuromuscular disease or spinal injury, IPPB may be useful in the acute phase to improve tidal volume and cough effectiveness" 07/01/1984 - "Pulmonary complications were defined as the development of 3 or more of 6 new findings: cough, phlegm, dyspnea, chest pain, temperature greater than 38 degrees C, pulse rate more than 100 beats/min. The frequency of development of pulmonary complications was 48% in the control group, 22% in the IPPB group (p less than 0.05), 21% in the IS group (p less than 0.05), and 22% in the DBE group (p less than 0.05)" Order ALL the reference details at left...
5.	Atelectasis 01/01/1985 - "In the treatment of postoperative atelectasis there are significant differences in the use of chest physical therapy, IPPB, and intermittent continuous positive airway pressure based on hospital size" 07/01/1981 - "Postoperative atelectasis: Intermittent positive pressure breathing, incentive spirometry, and face-mask positive end-expiratory pressure." 07/01/1980 - "Incentive spirometry, as a method for preventing postoperative atelectasis, was compared with intermittent positive-pressure breathing (IPPB) and resistance breathing in 126 patients undergoing upper-abdominal surgery, most of whom had cholecystectomy" 12/01/1979 - "Maximum volume IPPB for the management of pulmonary atelectasis." 03/01/1978 - "IPPB is not essential to prevention of atelectasis in postoperative cardiac surgical patients and may be inferior to other methods." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Albuterol (Salbutamol)
2.	Epinephrine (Adrenaline)
3.	Fenoterol
4.	Gases
5.	Aerosols
6.	Oxygen
7.	Isoproterenol (Isoprenaline)
8.	Droperidol
9.	Bronchodilator Agents (Bronchodilators)
10.	Terbutaline (Brethaire)

Related Therapies and Procedures

1.	Positive-Pressure Respiration (PEEP)
2.	Postural Drainage
3.	Continuous Positive Airway Pressure
4.	Mechanical Ventilators (Ventilator)
5.	Intermittent Positive-Pressure Breathing

Best Treatments:
Research Summary Report
on Chronic Obstructive Pulmonary Disease

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 790 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>